国际皮肤性病学杂志    2001 27 (2): 71-73   ISSN: 2096-5540  CN: 32-1880/R   银屑病治疗的新探索 赵春霞综述, 范小莉综述, 夏隆庆审校 中国医学科学院、中国协和医科大学 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Michaelsson G,Gerden B,Ottosson M,et al.Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin.Br J Dermatol,1993,129:667-673. [2] Michaelsson G.Kraaz W.Gerlen B,et al.Inereased lymphoytes infiltration in duodenal mucosa from patients with Psoriasis and serum IgA antibodies to gliadin.BrJ Dematol,1995,133:896-904. [3] Michaelsson G,Gerden B,Hagforsen E,et al.Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet.Br J Dermatol,2000,142(1):44-51. [4] Chalrmers RJ,Kirby B.Gluten and psoriasis.Br J Dermatol,2000,142(1):5-7. [5] Boehncke WH.Elshorst-Sehmidt T,Kaufmann R,et al.Systemic photodynamic therapy is a.safe and effective treatment for psoriasis.Arch Dermatol,2000,136:271-272. [6] Lehrer A,Bressanelli A,Wachsmann V,et al.Immunotherapy with Mvcobacterium vaccae in the treatment of psoriasis.FEMS Immunol Med Microbiol,1998,21(1):71-77. [7] Balagon MV,Walsh DS,Tan PL,et al.Improvement in psoriasis alter in tradermal administration of heat-killed Mycobaeterium vaeeae.Int J Dermatol,2000,39:51-58. [8] Guzzo C.Recent advances in the treatment of psoriasis.Dematol C1in,1997,15(1):59-68. [9] Harris DR.The art of treating psoriasis:practical suggestions fir improved treatment.Cutis,1999,64:335-336. [10] Orfanos CE.Treatment of psoriasis with retinoids:present status.Cutis,1999,64(5):347-353. [11] Lebwohl M,Poulin Y.Tazarotene in combinatiot with topical corticosteroids.JAtm Acad Dermatol,1998,39(4 Pt 2):S139-S143. [12] Lebwohl M,Asr E,Callen JP,et al.Once daily tazarotene gel versus twice daily fluocinonide cream in the treatment of plaque psoriasis.J Am Acad Dermatol,1998,38(5 Pt 1):705-711. [13] Lebwohl MG,Breneman DL,Goffe BS,et al.Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.J Am Acad Dermatol,1998,39(4 Pt 1):590-596. [14] Trozak DJ.Topical corticosteroid therapy in psoriasis vulgaris:update and new strategies.Cutis,1999,64(5):315-318. [15] Cunningham BB,Landells ID,Langman C,et al.Topical calcipotriene for morphea/linear scleroderma.J Am Acad Dermatol,1998,39(2 Pt 1)211-215. [16] Cunliffe WJ,Berth-Jones J,Claudy A,et al.Comparative study of calciptrial(MC903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.J Am Acad Dermatol,1992,26(5 Pt 1):736-743. [17] Lebwohl M,Siskin S,Epinette W,et al.A multiccnter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.J Am Acad Dermatol,1996,35(2 Pt 1):268-269. [18] Lebwohl M,Yoles A,Lombardi K,et al.Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis:effects on the duration of improvement.J Am Acad Dermatol,1998.39:447-450. [19] Ramsay CA,Schwartz BE,Lowson D,et al.Calcipotriol cream combined with twice weekly broad-band UVB phototherapy:a safe,effective and UVB-sparing antipsoriatric combination treatment.The Canadian Caleipotriol and UVB Study Group.Dermatology,2000,200:17-24. [20] Carrozza P,Hausermamn P,Nestle FO,ct al.Clinical efficacy of narrow band UVB(311 nm) combined with dithranol in psoriasis.An open pilot study.Dermatology,2000,200:35-39. 通讯作者: